share_log

Regeneron Pharmaceuticals | 8-K: Regeneron Reports First Quarter 2024 Financial and Operating Results

SEC ·  May 2, 2024 06:08
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more